Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Canaccord Genuity Initiates Coverage On WAVE Life Sciences with Buy Rating, Announces Price Target of $19

Author: Benzinga Newsdesk | August 04, 2025 08:27am

Canaccord Genuity analyst Whitney Ijem initiates coverage on WAVE Life Sciences (NASDAQ:WVE) with a Buy rating and announces Price Target of $19.

Posted In: WVE